WHO Approves Use of China’s CanSino COVID-19 Vaccine
[Asia Economy Reporter Jeon Jinyoung] The World Health Organization (WHO) has approved the use of the COVID-19 vaccine developed by the Chinese pharmaceutical company CanSino Biologics.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Hancom Breaks Away from Its 36-Year Mission and Formula for Success" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
According to foreign media on the 19th (local time), WHO stated in a press release that the vaccine meets the COVID-19 protection standards and that the benefits of using the vaccine outweigh the risks.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.